XETRA •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/04/2026 17:35
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization160,272 mln
Float539 mln
Earnings Date04/30/2026
EPS
12.26
Robust
P / E
22.55
Premium valuation
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.58
Likely reliable
Relative Strength
9
/ 100
Severely lagging
Debt / Equity
6.24
Extremely leveraged
Business Description
Founded in 1980 and based in Thousand Oaks, California, Amgen is a global biotechnology company focused on developing and producing medicines that treat serious conditions such as cancer, bone disease, heart disease, and autoimmune disorders. The company sells a wide range of products to hospitals, clinics, and pharmacies through wholesale distributors, reaching patients around the world. Amgen also works alongside partners like AstraZeneca, UCB, and BeiGene to expand its research and bring new treatments to market.
